Citations

Clear

653 citation(s) found for "Kantarci, Kejal".

Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis
Kattah, Andrea G. , Milić, Nataša , Kantarci, Kejal , Zeydan, Burcu , Kardia, Sharon L. R., Suarez, Maria L G, Turner, Stephen T. , Garovic, Vesna D. , Milic, N , Kantarci, Kejal , Zeydan, Burcu , Suarez, Maria Lourdes Gonzalez , Mosley, Thomas H. , Ware, Erin Bakshis

Mayo Clinic

Menopause | January 29, 2018 | Volume: 25 | Issue: 6 | Pages: 625-634

10.1097/gme.0000000000001062 | PMID 29381664 Get It

Abstract Objective: Experimental models suggest estrogen has a renoprotective effect, but human studies show variable results. Our objective was to study the association of hormone therapy (HT) and albuminuria in postmenopausal women and to synthesize the results with outcomes from prior studies. Methods: We analyzed data from postmenopausal women who participated in the second study visit (2000-2004) of the Genetic Epidemiology Network of Arteriopathy (GENOA) study. The exposure was self-reported HT use and the outcome was albuminuria (urine albumin-to-creatinine ratio >25 mg/g creatinine). We also conducted a systematic review and meta-analysis on the association of HT and urine protein in postmenopausal women. Continuous and dichotomous measures of protein excretion were converted to a standardized mean difference (SMD) for each study. Results: In the GENOA cohort ( n = 2,217), there were fewer women with albuminuria among HT users than nonusers (9% vs 19%, P < 0.001). HT use was associated with decreased odds of albuminuria (odds ratio 0.65, 95% confidence interval (CI), 0.45-0.95), after adjusting for significant differences in age, race, education, comorbidities, and the age at and cause of menopause. The SMD of the effect of HT on urine proteinuria/albuminuria in the randomized control trials ( n = 3) was 0.02 (95% CI, −0.29 to 0.33) and −0.13 (95% CI, −0.31 to 0.05) in the observational studies ( n = 9). There was significantly less albuminuria among HT users (SMD −0.15, 95% CI, −0.27 to −0.04) in the 9 studies that only reported albuminuria as an outcome and in the 10 studies with a comparator arm (SMD −0.15, 95% CI, −0.26 to −0.04). Conclusions: HT is associated with decreased odds of albuminuria, but some of the observed benefits may be related to reported outcomes, the presence of a comparator arm, and the type of study design.
Clinicopathological and 123I‐FP‐CIT SPECT correlations in patients with dementia
Jung, Youngsin, Jordan, Lennon, Lowe, Val J. , Kantarci, Kejal , Parisi, Joseph E. , Murray, Melissa E. , Reichard, Ross R., Ferman, Tanis J. , Graff‐Radford, Jonathan , Savica, Rodolfo , Fields, Julie A. , Allen, Laura A., Drubach, Daniel A., Louis, Erik K. St. , Silber, Michael H. , Jack, Clifford R. , Petersen, Ronald C. , Jordan, Lennon G, St Louis, Erik K, Jack, Clifford R , St Louis, E K , Kantarci, Kejal , Murray, Melissa E , Ferman, Tanis J , Dickson, Dennis W. , Jones, David T. , Machulda, Mary M. , Knopman, David S. , Boeve, Bradley F.

Mayo Clinic

Annals of Clinical and Translational Neurology | January 24, 2018 | Volume: 5 | Issue: 3 | Pages: 376-381

10.1002/acn3.521 | PMID 29560382 Get It

AbstractThe relationship between clinicopathologic diagnosis and 123I‐FP‐CIT SPECT in 18 patients with dementia (12 with Lewy body disease) from one center in the United States was assessed. The sensitivity and specificity of abnormal 123I‐FP‐CIT SPECT with reduced striatal uptake on visual inspection for predicting Lewy body disease were 91.7% and 83.3%, respectively. The mean calculated putamen to occipital ratio (mPOR) based on regions of interest was significantly reduced in Lewy body disease compared to non‐Lewy body disease cases (P = 0.002). In this study, abnormal 123I‐FP‐CIT SPECT was strongly associated with underlying Lewy body disease pathology, supporting the utility of 123I‐FP‐CIT SPECT in the clinical diagnosis of dementia with Lewy bodies.
Cohort profile: the Mayo Clinic Cohort Study of Oophorectomy and Aging-2 (MOA-2) in Olmsted County, Minnesota (USA)
Rocca, Walter A. , Rocca, Liliana Gazzuola , Shuster, Lynne T., Mielke, Michelle M. , Kantarci, Kejal , Miller, Virginia M. , Gazzuola Rocca, Liliana, Smith, Carin Y. , Grossardt, Brandon R. , Mielke, Michelle M , Kantarci, Kejal , Faubion, Stephanie S. , Stewart, Elizabeth A.

Mayo Clinic

BMJ Open | November 20, 2017 | Volume: 7 | Issue: 11 | Pages: e018861

10.1136/bmjopen-2017-018861 | PMID 29162577 Get It

Purpose This cohort study was established to investigate the effects of unilateral and bilateral oophorectomy on the ageing processes in women. Participants We used the records-linkage system of the Rochester Epidemiology Project (REP, http://www.rochesterproject.org ) to identify 570 women who underwent unilateral oophorectomy and 1653 women who underwent bilateral oophorectomy in Olmsted County, Minnesota from 1988 through 2007 (20 years). Each woman was matched by age (±1 year) to a population-based referent woman who had not undergone any oophorectomy (570 referent women) or bilateral oophorectomy (1653 referent women). These four cohorts are being followed to assess morbidity and mortality and to study imaging and biological markers related to ageing. Findings to date An extensive medical record abstraction using the REP has been completed for each woman to obtain demographic, reproductive and adult life characteristics and extensive clinical information about the surgical procedure and subsequent oestrogen replacement therapy (or other sex steroid therapy). The cohorts have been used to date to study the accumulation of multiple chronic conditions following bilateral oophorectomy in women with or without chronic conditions at the time of the oophorectomy (or index date). From the cohorts, we have also derived a sample of 128 pairs of women for a case–control study linking adverse childhood or adult experiences to the risk of bilateral oophorectomy. Future plans We hypothesise that the abrupt hormonal changes caused by bilateral oophorectomy in younger women have a major effect on the ageing processes across the full body. Therefore, we plan to investigate the risk of a wide range of chronic conditions following bilateral oophorectomy. Specific studies are underway for kidney diseases, psychiatric diseases and neurological diseases. In addition, we plan to invite a subsample of women from the bilateral oophorectomy cohort to participate in an in-person study involving brain imaging and the collection of biomarkers.
The limbic and neocortical contribution of α‐synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies
Ferman, Tanis J. , Aoki, Naoya , Murray, Melissa E. , Graff‐Radford, Neill R. , Gerpen, Jay A. van, Uitti, Ryan J. , Graff‐Radford, Jonathan, Pedraza, Otto , Kantarci, Kejal , Crook, Julia E. , Van Gerpen, Jay A, Kantarci, Kejal , Murray, Melissa E , Ferman, Tanis J , Wszołek, Zbigniew K. , Graff‐Radford, Jonathan , Boeve, Bradley F. , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 31, 2017 | Volume: 14 | Issue: 3 | Pages: 330-339

10.1016/j.jalz.2017.09.014 | PMID 29100980 Get It

AbstractIntroductionWe sought to assess the individual and combined contribution of limbic and neocortical α‐synuclein, tau, and amyloid β (Aβ) to duration of illness in dementia with Lewy bodies (DLB).MethodsQuantitative digital pathology of limbic and neocortical α‐synuclein, tau, and Aβ was assessed in 49 patients with clinically probable DLB. Regression modeling examined the unique and shared contribution of each pathology to the variance of illness duration.ResultsPatients with diffuse Lewy body disease had more severe pathology of each type and a shorter duration of illness than individuals with transitional Lewy body disease. The three pathologies accounted for 25% of the total variance of duration of illness, with 19% accounted for by α‐synuclein alone or in combination with tau and Aβ. When the diffuse Lewy body disease group was examined separately, α‐synuclein deposition significantly exceeded that of tau and Aβ. In this model, 20% of 24% total variance in the model for duration of illness was accounted for independently by α‐synuclein.DiscussionIn DLB, α‐synuclein is an important predictor of disease duration, both independently and synergistically with tau and Aβ.
Prevalence and Natural History of Superficial Siderosis
Pichler, Michael, Vemuri, Prashanthi , Aakre, Jeremiah A. , Flemming, Kelly D. , Brown, Robert D. , Kumar, Neeraj , Kantarci, Kejal , Kremers, Walter K. , Mielke, Michelle M. , Jack, Clifford R. , Petersen, Ronald C. , Lowe, Val J. , Graff‐Radford, Jonathan , Aakre, Jeremiah, Jack, Clifford R , Mielke, Michelle M , Vemuri, Prashanthi , Kantarci, Kejal , Rabinstein, Alejandro A. , Knopman, David S. , Kremers, Walter K , Flemming, Kelly D

Mayo Clinic

Stroke | October 26, 2017 | Volume: 48 | Issue: 12 | Pages: 3210-3214

10.1161/strokeaha.117.018974 | PMID 29070715 Get It

Background and Purpose— Superficial siderosis (SS) is characterized by hemosiderin deposition in the superficial layers of the central nervous system and can be seen during postmortem examination or with iron-sensitive magnetic resonance imaging techniques. The distribution of SS may predict the probable underlying cause. This study aimed to report the prevalence and natural history of SS in a population-based study. Methods— Brain magnetic resonance imaging scans from the MCSA (Mayo Clinic Study of Aging), a population-based study of residents 50 to 89 years of age in Olmsted County, Minnesota, were reviewed. Participants with imaging consistent with SS were identified from 2011 through 2016. An inverse probability weighting approach was used to convert our observed frequencies to population prevalence of SS. Additional data abstracted included amyloid positron emission tomography, Apolipoprotein E genotype, coexisting cerebral microbleeds, and extent of SS. Results— A total of 1412 participants had eligible magnetic resonance imaging scans. Two participants had infratentorial SS, restricted to the posterior fossa. Thirteen participants had cortical SS involving the cerebral convexities (7 focal and 6 disseminated). Only 3 of the participants with cortical SS (23%) also had cerebral microbleeds. The population prevalence of SS was 0.21% (95% confidence interval, 0–0.45) in those 50 to 69 years old and 1.43% (confidence interval, 0.53–2.34) in those over 69 years old. Apolipoprotein E ε2 allele was more common in those with SS (57.1% versus 15.0%; P <0.001). Compared with participants without SS, those with SS were also more likely to have a positive amyloid positron emission tomographic scan (76.9% versus 29.8%; P <0.001). Conclusions— SS may be encountered in the general elderly population. The association with increased amyloid burden and Apolipoprotein E ε2 genotype supports cerebral amyloid angiopathy as the most common mechanism. Longitudinal follow-up is needed to evaluate the risk of subsequent hemorrhage in cases of incidentally discovered SS.
[P1–334]: CHARACTERIZATION OF THE CLINICAL AND NEUROIMAGING FEATURES OF PATIENTS WITH DEMENTIA WITH LEWY BODIES ASSOCIATED WITH VARIANTS IN GLUCOCEREBROSIDASE (GBA)
Graff‐Radford, Neill R. , Radford, Jonathan Graff, Savica, Rodolfo , Przybelski, Scott A. , Lowe, Val J. , Petersen, Ronald C. , Boeve, Bradley F. , Ross, Owen A. , Kantarci, Kejal , Ferman, Tanis J. , Jones, David T. , Mielke, Michelle M. , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2017.06.350 Get It